The discovery that a protein called membralin promotes the survival of motor neurons could potentially lead to novel therapies for severe, early-onset motor neuron disease, according to a recent study by SBP investigators. As reported recently in eLife, the researchers developed a novel mouse model for identifying therapeutic targets for a class of motor neuron disorders called distal hereditary motor neuropathies. Continue reading “Newly identified cause of motor neuron disease paves way for better treatments”